Cleared Traditional

K180229 - RESCAN 700, CALLISTO eye (FDA 510(k) Clearance)

Jan 2019
Decision
350d
Days
Class 2
Risk

K180229 is an FDA 510(k) clearance for the RESCAN 700, CALLISTO eye. This device is classified as a Tomography, Optical Coherence (Class II - Special Controls, product code OBO).

Submitted by Carl Zeiss Meditec, AG (Jena, DE). The FDA issued a Cleared decision on January 11, 2019, 350 days after receiving the submission on January 26, 2018.

This device falls under the Ophthalmic FDA review panel. Regulated under 21 CFR 886.1570. Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases..

Submission Details

510(k) Number K180229 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 26, 2018
Decision Date January 11, 2019
Days to Decision 350 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF

Device Classification

Product Code OBO — Tomography, Optical Coherence
Device Class Class II - Special Controls
CFR Regulation 21 CFR 886.1570
Definition Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases.